[go: up one dir, main page]

CN111979185A - Mesenchymal stem cell adipogenic differentiation medium and application thereof - Google Patents

Mesenchymal stem cell adipogenic differentiation medium and application thereof Download PDF

Info

Publication number
CN111979185A
CN111979185A CN202010935109.XA CN202010935109A CN111979185A CN 111979185 A CN111979185 A CN 111979185A CN 202010935109 A CN202010935109 A CN 202010935109A CN 111979185 A CN111979185 A CN 111979185A
Authority
CN
China
Prior art keywords
mesenchymal stem
medium
adipogenic differentiation
stem cell
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010935109.XA
Other languages
Chinese (zh)
Other versions
CN111979185B (en
Inventor
于宝利
李其雷
陈旭
陈刚
杨建国
孙芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Ecosai Biotechnology Co ltd
Original Assignee
Excell Biology Taicang Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Excell Biology Taicang Co ltd filed Critical Excell Biology Taicang Co ltd
Priority to CN202010935109.XA priority Critical patent/CN111979185B/en
Publication of CN111979185A publication Critical patent/CN111979185A/en
Application granted granted Critical
Publication of CN111979185B publication Critical patent/CN111979185B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653Adipocytes; Adipose tissue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14Calcium; Ca chelators; Calcitonin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/16Magnesium; Mg chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/22Zinc; Zn chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/40Nucleotides, nucleosides or bases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/46Amines, e.g. putrescine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/33Insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/385Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90Polysaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1353Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1369Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from blood-borne mesenchymal stem cells, e.g. MSC from umbilical blood
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1384Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from adipose-derived stem cells [ADSC], from adipose stromal stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1392Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to a mesenchymal stem cell adipogenic differentiation culture medium and application thereof, which is characterized by comprising a basic culture medium and additive components, wherein the culture medium comprises optimally designed components such as various inorganic salts, amino acids, vitamins and the like, and components such as recombinant human serum albumin, sodium carboxymethylcellulose, 3-isobutyl-1-methylxanthine, recombinant human insulin, dexamethasone, pioglitazone hydrochloride, palmitic acid, oleic acid, linoleic acid, cholesterol and the like. According to the invention, through optimally designing the addition and the proportion of each component, the capability of the culture medium for inducing the mesenchymal stem cells to differentiate into the adipocytes is obviously improved, and the differentiation time is further shortened.

Description

一种间充质干细胞成脂分化培养基及其应用A kind of mesenchymal stem cell adipogenic differentiation medium and its application

技术领域technical field

本发明属于属于细胞培养技术领域,具体涉及一种间充质干细胞成脂分化培养基及其用。The invention belongs to the technical field of cell culture, and in particular relates to a mesenchymal stem cell adipogenic differentiation medium and use thereof.

背景技术Background technique

间充质干细胞(Mesenchymal stem cells,MSCs),起源于中胚层,是一种多能干细胞,主要存在于结缔组织和器官间质中,具有强大的自我更新和多向分化能力,具有在体外分化为脂肪细胞、骨细胞、软骨细胞、神经细胞等多种细胞的能力。Mesenchymal stem cells (MSCs), originating from the mesoderm, are a kind of pluripotent stem cells that mainly exist in connective tissues and organ interstitium. It is the ability of various cells such as fat cells, bone cells, cartilage cells, and nerve cells.

间充质干细胞来源丰富,广泛存在于骨髓、脂肪、脐带等组织,具有来源方便,易于分离、培养、扩增和纯化,多次传代扩增后仍具有干细胞特性,并且具有低免疫原性,异体移植排异较轻,配型要求不严格;具有免疫调节功能,通过细胞间的相互作用及产生细胞因子抑制T细胞的增殖及其免疫反应,从而发挥免疫重建的功能;正是由于拥有这些特性,使得间充质干细胞能够提供一种理想的生物学平台,用于科学研究与临床应用,如细胞治疗、再生医学、药物筛选、基因治疗载体的建立、细胞发育与分化的分子调节机制研究、组织工程种子细胞等。Mesenchymal stem cells are rich in sources and widely exist in bone marrow, fat, umbilical cord and other tissues. They have convenient sources and are easy to separate, culture, expand and purify. After multiple passages and expansions, they still have stem cell characteristics and have low immunogenicity. Allograft rejection is relatively mild, and the matching requirements are not strict; it has an immunoregulatory function, and inhibits the proliferation and immune response of T cells through the interaction between cells and the production of cytokines, thereby exerting the function of immune reconstruction; it is precisely because of these The characteristics of mesenchymal stem cells make mesenchymal stem cells provide an ideal biological platform for scientific research and clinical applications, such as cell therapy, regenerative medicine, drug screening, establishment of gene therapy vectors, and research on molecular regulation mechanisms of cell development and differentiation , tissue engineering seed cells, etc.

无论在科学研究还是临床应用上,间充质干细胞的鉴定一直是需要面对的问题。更由于临床应用的特殊性,用于细胞治疗的间充质干细胞的鉴定越来越受到重视,国家有关部门也出台了相关文件,《干细胞临床研究管理办法(试行)》(国卫科教发〔2015〕48号)和《干细胞制剂质量控制及临床前研究指导原则(试行)》明确提出可通过检测干细胞分化潜能、诱导分化细胞的结构和生理功能、对免疫细胞的调节能力、分泌特定细胞因子、表达特定基因和或蛋白等功能,判断干细胞制剂与治疗相关的生物学有效性。对间充质干细胞,无论何种来源,应进行体外多种类型细胞(如成脂肪细胞、成软骨细胞、成骨细胞等)分化能力的检测,以判断其细胞分化的多能性。Whether in scientific research or clinical application, the identification of mesenchymal stem cells has always been a problem that needs to be faced. Due to the particularity of clinical applications, the identification of mesenchymal stem cells used for cell therapy has received more and more attention, and relevant national departments have also issued relevant documents, "Administrative Measures for Stem Cell Clinical Research (Trial)" (National Health Science and Education Development [ 2015] No. 48) and "Guidelines for Quality Control and Preclinical Research of Stem Cell Preparations (Trial)" clearly stated that the differentiation potential of stem cells, the structure and physiological function of induced differentiated cells, the ability to regulate immune cells, and the secretion of specific cytokines can be clearly identified. , expression of specific genes and or proteins, etc., to judge the biological effectiveness of stem cell preparations and treatment. For mesenchymal stem cells, regardless of the source, the differentiation ability of various types of cells (such as adipocytes, chondroblasts, osteoblasts, etc.) should be tested in vitro to determine the pluripotency of cell differentiation.

目前也有效果较好的商业化培养基,如STEMCELL公司的成脂分化培养基产品(STEMCELL,05412),分化效果优良,在部分间充质干细胞中可以实现7-14天成脂分化,但是该培养基成本很高。At present, there are also commercial mediums with good effects, such as the adipogenic differentiation medium product of STEMCELL (STEMCELL, 05412), which has excellent differentiation effect and can achieve adipogenic differentiation in some mesenchymal stem cells for 7-14 days. Base costs are high.

目前也有同类型专利申请,通常采用胎牛血清、胰岛素、3-异丁基-1-甲基黄嘌呤、糖皮质激素和噻唑烷二酮等物质协同作用,诱导成脂分化,虽然这些成分也能诱导间充质干细胞的成脂分化,但是其分化效率较低,所用时间较长,存在效能不足的缺陷。At present, there are also patent applications of the same type, which usually use substances such as fetal bovine serum, insulin, 3-isobutyl-1-methylxanthine, glucocorticoids and thiazolidinediones to synergize to induce adipogenic differentiation, although these components also It can induce adipogenic differentiation of mesenchymal stem cells, but its differentiation efficiency is low, it takes a long time, and it has the defect of insufficient efficiency.

发明内容SUMMARY OF THE INVENTION

针对现有技术中的不足,本发明设计开发了一种新的间充质干细胞培养基。Aiming at the deficiencies in the prior art, the present invention designs and develops a new medium for mesenchymal stem cells.

本发明的第一个目的是,针对现有成脂分化培养基分化效率低、分化时间长的不足,提供一种间充质干细胞成脂分化培养基,可以实现更短时间诱导间充质干细胞向脂肪细胞的分化。The first object of the present invention is to provide a mesenchymal stem cell adipogenic differentiation medium for the shortcomings of low differentiation efficiency and long differentiation time of the existing adipogenic differentiation medium, which can induce mesenchymal stem cells in a shorter time. Differentiation into adipocytes.

本发明的第二个目的是,提供间充质干细胞成脂分化培养基的用途。The second object of the present invention is to provide the use of a mesenchymal stem cell adipogenic differentiation medium.

为了实现上述第一个目的,本发明采用的技术方案是:In order to realize the above-mentioned first purpose, the technical scheme adopted in the present invention is:

基础培养基和添加组分组成,基础培养基由无机盐组分、氨基酸组分、维生素组分、核苷酸组分、微量元素组分和碳水化合物组成,添加组分由重组人血清白蛋白、羧甲基纤维素钠、3-异丁基-1-甲基黄嘌呤、重组人胰岛素、地塞米松、匹格列酮盐酸盐、棕榈酸、油酸、亚油酸、胆固醇组成。The basal medium and supplementary components are composed of inorganic salt components, amino acid components, vitamin components, nucleotide components, trace element components and carbohydrates, and the supplementary components are composed of recombinant human serum albumin , Sodium carboxymethylcellulose, 3-isobutyl-1-methylxanthine, recombinant human insulin, dexamethasone, pioglitazone hydrochloride, palmitic acid, oleic acid, linoleic acid, cholesterol.

优选的,添加组分以体积计,各成分的含量为:重组人血清白蛋白100g/L、羧甲基纤维素钠100g/L、3-异丁基-1-甲基黄嘌呤50mM、重组人胰岛素500uM、地塞米松50uM、匹格列酮盐酸盐1mM、棕榈酸3mM、油酸1mM、亚油酸3mM、胆固醇1mM;Preferably, the added components are calculated by volume, and the content of each component is: recombinant human serum albumin 100g/L, sodium carboxymethyl cellulose 100g/L, 3-isobutyl-1-methylxanthine 50mM, recombinant Human insulin 500uM, dexamethasone 50uM, pioglitazone hydrochloride 1mM, palmitic acid 3mM, oleic acid 1mM, linoleic acid 3mM, cholesterol 1mM;

基础培养基与添加组分的体积比为100:0.1~100:3。The volume ratio of the basal medium to the added components is 100:0.1 to 100:3.

优选的,基础培养基与添加组分的体积比为100:1。Preferably, the volume ratio of basal medium to supplementary components is 100:1.

优选的,基础培养基,成分组成如下:Preferably, the basal medium is composed of the following components:

Figure BDA0002671651080000031
Figure BDA0002671651080000031

Figure BDA0002671651080000041
Figure BDA0002671651080000041

为了实现上述第二个目的,本发明采用的技术方案是:In order to realize the above-mentioned second purpose, the technical scheme adopted in the present invention is:

间充质干细胞成脂分化培养基用于脂肪、骨髓、脐带、骨骼肌等来源的间充质干细胞体外诱导成脂分化的用途。The adipogenic differentiation medium of mesenchymal stem cells is used for inducing adipogenic differentiation of mesenchymal stem cells derived from fat, bone marrow, umbilical cord, skeletal muscle and the like in vitro.

由于上述技术方案的运用,本发明与现有技术相比具有以下优点:Due to the application of the above-mentioned technical solutions, the present invention has the following advantages compared with the prior art:

本发明通过独特的基础培养基配方设计,更适用于间充质干细胞的培养;The invention is more suitable for the culture of mesenchymal stem cells through the unique design of the basic medium formula;

本发明的培养基内添加重组人血白蛋白及羧甲基纤维素钠等成分,不含有人源提取物质成分,不含有动物源成分,成分明确,不需要进行艾滋病病毒(HIV-1/2)抗体、乙肝表面抗原(HBsAg)抗体和丙肝病毒(HCV)检测,同时可排除人畜共患病风险,使用更安全、便利,减少质控需求,下游细胞诱导分化应用更安全。The medium of the present invention is added with components such as recombinant human albumin and sodium carboxymethyl cellulose, does not contain human-derived extract material components, does not contain animal-derived components, has clear components, and does not require HIV-1/2 ) antibody, hepatitis B surface antigen (HBsAg) antibody and hepatitis C virus (HCV) detection, at the same time, it can exclude the risk of zoonotic disease, it is safer and more convenient to use, reduces the need for quality control, and the application of downstream cell induction and differentiation is safer.

本发明的培养基添加多种脂肪酸组合,配合多种细胞因子3-异丁基-1-甲基黄嘌呤、重组人胰岛素生长因子、地塞米松、匹格列酮盐酸盐协同作用,能够快速的在体外诱导间充质干细胞向成熟脂肪细胞分化,分化效率更高,可以更短时间内检测到分化细胞的形成。The culture medium of the present invention is supplemented with various combinations of fatty acids and cooperated with various cytokines 3-isobutyl-1-methylxanthine, recombinant human insulin growth factor, dexamethasone, and pioglitazone hydrochloride to synergize, and can Rapidly induce the differentiation of mesenchymal stem cells into mature adipocytes in vitro, the differentiation efficiency is higher, and the formation of differentiated cells can be detected in a shorter time.

附图说明Description of drawings

图1:实施例2间充质干细胞成脂分化培养基体外诱导人脂肪间充质干细胞(P6)成脂分化第12天油红0染色结果。Figure 1: The results of oil red 0 staining on the 12th day of in vitro induction of adipogenic differentiation of human adipose-derived mesenchymal stem cells (P6) by mesenchymal stem cell adipogenic differentiation medium in Example 2.

图2:实施例3中M1~M5所述间充质干细胞成脂分化培养基体外诱导人脂肪间充质干细胞(P6)成脂分化第12天油红0染色结果。Figure 2: The results of oil red 0 staining on the 12th day of in vitro induction of adipogenic differentiation of human adipose-derived mesenchymal stem cells (P6) by the mesenchymal stem cell adipogenic differentiation medium described in M1-M5 in Example 3.

具体实施方式Detailed ways

正如背景技术中介绍的,成脂分化能力是间充质干细胞的基本的能力,而如何快速、高效的在体外诱导间充质干细胞分化成为成熟脂肪细胞是间充质干细胞研究及应用的重要一环。为了提高间充质干细胞成脂分化的速度、效率,需要研发出一种间充质干细胞成脂分化无培养基。本发明通过在基础培养基中加入成脂分化诱导因子、血清、脂肪酸等成分,达到快速、高效的体外诱导间充质干细胞向成熟脂肪细胞分化。As introduced in the background art, adipogenic differentiation ability is the basic ability of mesenchymal stem cells, and how to quickly and efficiently induce mesenchymal stem cells to differentiate into mature adipocytes in vitro is an important part of the research and application of mesenchymal stem cells. ring. In order to improve the speed and efficiency of mesenchymal stem cell adipogenic differentiation, it is necessary to develop a mesenchymal stem cell adipogenic differentiation-free medium. The invention achieves rapid and efficient in vitro induction of mesenchymal stem cells to differentiate into mature adipocytes by adding adipogenic differentiation inducing factors, serum, fatty acids and other components into the basal medium.

实施例1Example 1

本实施例提供的间充质干细胞成脂分化培养基由以下成分组成:基础培养基和添加组分。The mesenchymal stem cell adipogenic differentiation medium provided in this example consists of the following components: basal medium and supplementary components.

(1)基础培养基标记为Basal,按如下方案配制:(1) The basal medium is marked as Basal, and is prepared according to the following scheme:

Figure BDA0002671651080000061
Figure BDA0002671651080000061

Figure BDA0002671651080000071
Figure BDA0002671651080000071

上述各种组分均可从Sigma、阿拉丁等试剂公司购得,各组分溶于1L注射水内,以0.22微米滤膜过滤,即得到基础培养基Basal。The above-mentioned various components can be purchased from Sigma, Aladdin and other reagent companies. Each component is dissolved in 1 L of water for injection, and filtered with a 0.22-micron membrane to obtain the basic medium Basal.

(2)添加组分记为SUP1组分,SUP1组分物质组成如下:(2) The added components are recorded as SUP1 components, and the composition of SUP1 components is as follows:

Figure BDA0002671651080000081
Figure BDA0002671651080000081

本例中,3-异丁基-1-甲基黄嘌呤、地塞米松、匹格列酮盐酸盐可溶于DMSO,棕榈酸、油酸、亚油酸、胆固醇可溶于无水乙醇,重组人血清白蛋白,羧甲基纤维素钠可溶于注射水,重组胰岛素可溶于0.3M的盐酸溶液,以上各成分溶解后,按上表添加量混合,以0.22微米滤膜过滤,即得到SUP1溶液。In this example, 3-isobutyl-1-methylxanthine, dexamethasone, and pioglitazone hydrochloride are soluble in DMSO, while palmitic acid, oleic acid, linoleic acid, and cholesterol are soluble in absolute ethanol , recombinant human serum albumin, sodium carboxymethyl cellulose can be dissolved in water for injection, and recombinant insulin can be dissolved in 0.3M hydrochloric acid solution. That is, the SUP1 solution is obtained.

本例中,间充质干细胞成脂分化培养基以Basal与SUP1按体积比1000mL:10mL配制而成。In this example, the mesenchymal stem cell adipogenic differentiation medium was prepared with Basal and SUP1 in a volume ratio of 1000mL:10mL.

对比例1Comparative Example 1

为商品化成脂分化培养基(STEMCELL,05412)。It is a commercial adipogenic differentiation medium (STEMCELL, 05412).

对比例2Comparative Example 2

为阴性对照,为常规培养组,所用培养液为DMEM/F12培养基(Sigma,D2906)内添加10%FBS(ExCell Bio,FND500)。As a negative control, it is a conventional culture group, and the culture medium used is DMEM/F12 medium (Sigma, D2906) supplemented with 10% FBS (ExCell Bio, FND500).

实施例2Example 2

本实施例提供实施例1的间充质干细胞成脂分化培养基的效果验证,本例设置1个实验组(实施例1)和2个对照组(对比例1、对比例2)。本实施例的实验中采用人脂肪间充质干细胞(AD-MSCs),该细胞来源于ATCC标准细胞库(PCS-500-011,Lot 80622175,ATCC),此细胞用于下述所有实验。This example provides verification of the effect of the mesenchymal stem cell adipogenic differentiation medium of Example 1. This example sets up one experimental group (Example 1) and two control groups (Comparative Example 1, Comparative Example 2). Human adipose-derived mesenchymal stem cells (AD-MSCs) were used in the experiments in this example, and the cells were derived from the ATCC standard cell bank (PCS-500-011, Lot 80622175, ATCC), and the cells were used in all experiments described below.

一、实验方法1. Experimental method

1、AD-MSCs的复苏1. Recovery of AD-MSCs

从细胞工作库中取1支P6代的AD-MSCs,37℃水浴中迅速使其溶解。将细胞缓慢加入10mL间充质干细胞培养基中(ExCell Bio,ME000-N023),吹打均匀后,计数,300g离心5分钟。用适量间充质干细胞培养基(ExCell Bio,ME000-N023)重悬细胞,并按8000/cm2密度将细胞接种于100mm培养皿,摇匀后置于37℃,5%CO2,饱和湿度环境下培养。Take 1 AD-MSCs at passage P6 from the cell working bank, and dissolve them quickly in a 37°C water bath. The cells were slowly added to 10 mL of mesenchymal stem cell medium (ExCell Bio, ME000-N023), pipetted evenly, counted, and centrifuged at 300 g for 5 minutes. Resuspend the cells with an appropriate amount of mesenchymal stem cell medium (ExCell Bio, ME000-N023), and inoculate the cells in a 100mm culture dish at a density of 8000/cm 2 , shake well and place at 37°C, 5% CO 2 , saturated humidity cultivated in the environment.

2、AD-MSCs的传代培养2. Subculture of AD-MSCs

当AD-MSCs在培养皿中汇合度达到80-90%时,用移液管吸弃培养皿中旧培养液。加入5mL DPBS洗涤细胞,弃去DPBS,加入0.5%胰蛋白酶-0.4%EDTA溶液,消化细胞。待细胞收缩变圆时立即弃去0.5%胰蛋白酶-0.4%EDTA溶液,并加入5mL间充质干细胞培养基。重悬,收集细胞,计数,300g离心5分钟。弃去上清,加入5mL间充质干细胞培养基,按20000/cm2重新接种细胞至12孔板,细胞培养24h后进行诱导分化。When the AD-MSCs reached 80-90% confluence in the petri dish, use a pipette to remove the old medium in the petri dish. 5 mL of DPBS was added to wash the cells, the DPBS was discarded, and 0.5% trypsin-0.4% EDTA solution was added to digest the cells. When the cells contracted and became round, the 0.5% trypsin-0.4% EDTA solution was immediately discarded, and 5 mL of mesenchymal stem cell medium was added. Resuspend, collect cells, count, and centrifuge at 300g for 5 minutes. The supernatant was discarded, 5 mL of mesenchymal stem cell medium was added, and the cells were re-seeded to a 12-well plate at 20,000/cm 2 , and the cells were cultured for 24 hours to induce differentiation.

3、AD-MSCs成脂诱导分化3. Adipogenic differentiation of AD-MSCs

1)培养基1) Culture medium

使用实施例1、对比例1、对比例2中所述培养基进行间充质干细胞向脂肪细胞的诱导分化。Induction and differentiation of mesenchymal stem cells into adipocytes were performed using the medium described in Example 1, Comparative Example 1, and Comparative Example 2.

2)成脂诱导分化方法2) Adipogenic induction and differentiation method

传代细胞20000/cm2重新接种细胞至12孔板,细胞培养24h后进行诱导分化,每孔加入实施例1、对比例1、对比例2所述的培养基进行诱导分化,每2天更换新鲜培养基,诱导分化5-12天后进行油红O染色。20000/cm 2 of passaged cells were re-seeded into 12-well plates, and cells were cultured for 24 h to induce differentiation. The culture medium described in Example 1, Comparative Example 1, and Comparative Example 2 was added to each well to induce differentiation, and fresh cells were replaced every 2 days. Medium, oil red O staining was performed 5-12 days after induction of differentiation.

3)油红O染色3) Oil red O staining

分化结束后,从12孔细胞培养板中吸去分化培养基,加入1mL DPBS,轻轻润洗孔板底部,吸去DPBS;在通风橱内,加入1mL 4%甲醛溶液,轻轻晃动培养板,使底面浸润均匀,室温静置30分钟;弃去固定液,加入1mL DPBS,润洗细胞2次,加入500uL 0.3%的油红O染液(Sigma,O1391)常温染色15分钟;吸去染液,加入1mL DPBS润洗3次,在倒置光学显微镜20倍物镜下观察并采集图片,同时使用CSI设备进行脂肪滴丰度值计算。After the differentiation, aspirate the differentiation medium from the 12-well cell culture plate, add 1 mL of DPBS, gently rinse the bottom of the well plate, and aspirate the DPBS; add 1 mL of 4% formaldehyde solution in a fume hood, and shake the culture plate gently , make the bottom surface evenly infiltrated, and let stand at room temperature for 30 minutes; discard the fixative, add 1 mL of DPBS, rinse the cells twice, add 500uL of 0.3% Oil Red O staining solution (Sigma, O1391) for 15 minutes at room temperature for staining; Add 1 mL of DPBS to rinse 3 times, observe and collect pictures under an inverted optical microscope with a 20x objective lens, and use CSI equipment to calculate the abundance of fat droplets.

结果显示:各培养组细胞出现脂肪滴时间如下表1所示,采用实施例1的分化培养基出现脂肪滴的时间更早,分化12天采用实施例1培养基细胞分化效果更好(如图1所示),脂肪滴丰度值更高(如表1所示)。The results show that: the time for the appearance of fat droplets in the cells of each culture group is shown in Table 1 below, the time for the appearance of fat droplets in the differentiation medium of Example 1 is earlier, and the differentiation effect of cells in the medium of Example 1 is better for 12 days of differentiation (as shown in the figure). 1), the fat droplet abundance values were higher (as shown in Table 1).

表1实施例2间充质干细胞分化检测Table 1Example 2 Mesenchymal Stem Cell Differentiation Detection

Figure BDA0002671651080000101
Figure BDA0002671651080000101

实施例3Example 3

本实施例提供不同配比效果测试,按照本例实施例1的方案配制基础培养基(Basal)和添加组分(SUP1),基础培养基与添加组分按照不同配比进行间充质干细胞成脂分化培养基的配制,并检验各配比培养基的成脂诱导分化的效果。诱导分化12天后进行油红O染色。本实施例使用的人脂肪间充质干细胞及培养方法与实施例2中相同。This example provides a test of the effect of different ratios. The basal medium (Basal) and the supplementary components (SUP1) are prepared according to the scheme of Example 1 of this example, and the basal medium and the supplementary components are prepared according to different ratios of mesenchymal stem cells. Adipogenic differentiation medium was prepared, and the effect of adipogenic induction and differentiation of each proportioning medium was tested. Oil red O staining was performed 12 days after induction of differentiation. The human adipose-derived mesenchymal stem cells and the culture method used in this example are the same as those in Example 2.

1)培养基1) Culture medium

Figure BDA0002671651080000111
Figure BDA0002671651080000111

2)成脂诱导分化方法2) Adipogenic induction and differentiation method

传代细胞20000/cm2重新接种细胞至12孔板,细胞培养24h后进行诱导分化,每孔加入实施例1、对比例1、对比例2所述的培养基进行诱导分化,每2天更换新鲜培养基,诱导分化5-12天后进行油红O染色。20000/cm 2 of passaged cells were re-seeded into 12-well plates, and cells were cultured for 24 h to induce differentiation. The culture medium described in Example 1, Comparative Example 1, and Comparative Example 2 was added to each well to induce differentiation, and fresh cells were replaced every 2 days. Medium, oil red O staining was performed 5-12 days after induction of differentiation.

3)油红O染色3) Oil red O staining

从12孔细胞培养板中吸去分化培养基,加入1mL DPBS,轻轻润洗孔板底部,吸去DPBS;在通风橱内,加入1mL 4%甲醛溶液,轻轻晃动培养板,使底面浸润均匀,室温静置30分钟;弃去固定液,加入1mL DPBS,润洗细胞2次,加入500uL 0.3%的油红O染液(Sigma,O1391)常温染色15分钟;吸去染液,加入1mL DPBS润洗3次,在倒置光学显微镜10倍物镜下观察并采集图片,同时使用CSI设备进行脂肪滴丰度值计算。Aspirate the differentiation medium from the 12-well cell culture plate, add 1 mL of DPBS, gently rinse the bottom of the well plate, and aspirate the DPBS; in a fume hood, add 1 mL of 4% formaldehyde solution, shake the culture plate gently to infiltrate the bottom surface Evenly, let stand at room temperature for 30 minutes; discard the fixative, add 1 mL of DPBS, rinse the cells twice, add 500uL of 0.3% Oil Red O staining solution (Sigma, O1391) for 15 minutes at room temperature for staining; remove the staining solution, add 1 mL Rinse with DPBS three times, observe and collect pictures under an inverted optical microscope with a 10x objective lens, and use CSI equipment to calculate the abundance of fat droplets.

如下表2及附图2所示,结果显示:M3培养基Basal:SUP1的配比,采用100:1的比例配制的分化培养基分化效果最佳;M1、M2、M4培养基Basal:SUP1配比的培养基也可诱导间充质干细胞向脂肪细胞分化,分化效果M2优于M3,M3优于M1;M5培养基,Basal:SUP1的配比采用100:5的配比,具有细胞毒性,细胞致死,无法实现细胞分化。As shown in Table 2 and Figure 2 below, the results show that: the ratio of M3 medium Basal: SUP1, the differentiation medium prepared in the ratio of 100:1 has the best differentiation effect; M1, M2, M4 medium Basal: SUP1 mix The ratio of medium can also induce mesenchymal stem cells to differentiate into adipocytes, and the differentiation effect of M2 is better than M3, and M3 is better than M1; M5 medium, the ratio of Basal:SUP1 is 100:5, which has cytotoxicity. Cells are lethal and cell differentiation cannot be achieved.

表2实施例3间充质干细胞分化检测Table 2Example 3 Mesenchymal Stem Cell Differentiation Detection

序号serial number Basal:SUP1Basal: SUP1 分化12天脂肪滴丰度Abundance of fat droplets at day 12 of differentiation M1M1 100:0.1100:0.1 88 M2M2 100:0.5100: 0.5 22twenty two M3M3 100:1100:1 3333 M4M4 100:3100:3 1515 M5M5 100:5100:5 细胞凋亡apoptosis

最后所应当说明的是,以上实施例仅用以说明本发明的技术方案而非对本发明保护范围的限制,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and not to limit the protection scope of the present invention. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention, All should be included within the protection scope of the present invention.

Claims (6)

1.一种间充质干细胞成脂分化培养基,其特征在于,由基础培养基和添加组分组成,所述基础培养基由无机盐组分、氨基酸组分、维生素组分、核苷酸组分、微量元素组分和碳水化合物组成;所述添加组分由重组人血清白蛋白、羧甲基纤维素钠、3-异丁基-1-甲基黄嘌呤、重组人胰岛素、地塞米松、匹格列酮盐酸盐、棕榈酸、油酸、亚油酸、胆固醇组成。1. a mesenchymal stem cell adipogenic differentiation medium, is characterized in that, is made up of basal medium and added component, and described basal medium is composed of inorganic salt component, amino acid component, vitamin component, nucleotide Components, trace element components and carbohydrates; the added components are composed of recombinant human serum albumin, sodium carboxymethyl cellulose, 3-isobutyl-1-methylxanthine, recombinant human insulin, dexamethasone Metasone, pioglitazone hydrochloride, palmitic acid, oleic acid, linoleic acid, cholesterol. 2.根据权利要求1所述的间充质干细胞成脂分化培养基,其特征在于,所述添加组分以体积计,各组成成分的含量为:重组人血清白蛋白100g/L、羧甲基纤维素钠100g/L、3-异丁基-1-甲基黄嘌呤50mM、重组人胰岛素500uM、地塞米松50uM、匹格列酮盐酸盐1mM、棕榈酸3mM、油酸1mM、亚油酸3mM、胆固醇1mM;2. The mesenchymal stem cell adipogenic differentiation medium according to claim 1, wherein the added components are in volume, and the content of each component is: recombinant human serum albumin 100g/L, carboxymethyl Cellulose sodium 100g/L, 3-isobutyl-1-methylxanthine 50mM, recombinant human insulin 500uM, dexamethasone 50uM, pioglitazone hydrochloride 1mM, palmitic acid 3mM, oleic acid 1mM, sub Oleic acid 3mM, cholesterol 1mM; 所述基础培养基与添加组分的体积比为100:0.1~100:3。The volume ratio of the basic medium to the added components is 100:0.1-100:3. 3.根据权利要求2所述的间充质干细胞成脂分化培养基,其特征在于,所述基础培养基与添加组分的体积比为100:1。3 . The mesenchymal stem cell adipogenic differentiation medium according to claim 2 , wherein the volume ratio of the basal medium to the added components is 100:1. 4 . 4.根据权利要求1-3任一所述的间充质干细胞成脂分化培养基,其特征在于,所述的基础培养基,成分组成如下:4. according to the arbitrary described mesenchymal stem cell adipogenic differentiation medium of claim 1-3, it is characterized in that, described basal medium, composition is as follows:
Figure FDA0002671651070000011
Figure FDA0002671651070000011
Figure FDA0002671651070000021
Figure FDA0002671651070000021
Figure FDA0002671651070000031
Figure FDA0002671651070000031
.
5.权利要求1-4任一所述的间充质干细胞成脂分化培养基在间充质干细胞体外成脂分化中的用途。5. Use of the mesenchymal stem cell adipogenic differentiation medium of any one of claims 1-4 in the in vitro adipogenic differentiation of mesenchymal stem cells. 6.根据权利要求5所述的间充质干细胞体外成脂分化中的用途,其特征在于,所述的间充质干细胞来源于脂肪、骨髓、脐带、骨骼肌中的任一组织。6 . The use of mesenchymal stem cells in adipogenic differentiation in vitro according to claim 5 , wherein the mesenchymal stem cells are derived from any tissue in fat, bone marrow, umbilical cord, and skeletal muscle. 7 .
CN202010935109.XA 2020-09-08 2020-09-08 Mesenchymal stem cell adipogenic differentiation medium and application thereof Active CN111979185B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010935109.XA CN111979185B (en) 2020-09-08 2020-09-08 Mesenchymal stem cell adipogenic differentiation medium and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010935109.XA CN111979185B (en) 2020-09-08 2020-09-08 Mesenchymal stem cell adipogenic differentiation medium and application thereof

Publications (2)

Publication Number Publication Date
CN111979185A true CN111979185A (en) 2020-11-24
CN111979185B CN111979185B (en) 2022-07-19

Family

ID=73447740

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010935109.XA Active CN111979185B (en) 2020-09-08 2020-09-08 Mesenchymal stem cell adipogenic differentiation medium and application thereof

Country Status (1)

Country Link
CN (1) CN111979185B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003052360A (en) * 2001-08-20 2003-02-25 Japan Science & Technology Corp Culture method of mesenchymal stem cells using basement membrane extracellular matrix
CN105779387A (en) * 2016-05-10 2016-07-20 张君 Method of induced differentiation of rat bone marrow mesenchymal stem cells into adipocytes
CN106754664A (en) * 2016-12-26 2017-05-31 广州赛莱拉干细胞科技股份有限公司 It is a kind of to induce the culture medium that break up into fat of Skeletal Muscle derived stem cells and its apply and into fat differentiation method
CN108192860A (en) * 2017-12-27 2018-06-22 重庆斯德姆生物技术有限公司 A kind of culture medium and abductive approach that amnion mesenchymal stem cell is induced to break up into fat
CN108588015A (en) * 2018-03-06 2018-09-28 安徽瑞杰赛尔生物科技有限公司 A kind of human mesenchymal stem cell adipogenic induction differential medium and preparation method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003052360A (en) * 2001-08-20 2003-02-25 Japan Science & Technology Corp Culture method of mesenchymal stem cells using basement membrane extracellular matrix
CN105779387A (en) * 2016-05-10 2016-07-20 张君 Method of induced differentiation of rat bone marrow mesenchymal stem cells into adipocytes
CN106754664A (en) * 2016-12-26 2017-05-31 广州赛莱拉干细胞科技股份有限公司 It is a kind of to induce the culture medium that break up into fat of Skeletal Muscle derived stem cells and its apply and into fat differentiation method
CN108192860A (en) * 2017-12-27 2018-06-22 重庆斯德姆生物技术有限公司 A kind of culture medium and abductive approach that amnion mesenchymal stem cell is induced to break up into fat
CN108588015A (en) * 2018-03-06 2018-09-28 安徽瑞杰赛尔生物科技有限公司 A kind of human mesenchymal stem cell adipogenic induction differential medium and preparation method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
吴迪等: "无动物源性成分培养基体外扩增的间充质干细胞", 《中国组织工程研究》 *
杜敏清等: "猪骨髓间充质干细胞成脂成肌分化的诱导分化", 《中国畜牧兽医学会动物营养学分会第十一次全国动物营养学术研讨会论文集》 *
陈犹白等: "脂肪干细胞成脂分化的研究进展", 《中国美容医学》 *

Also Published As

Publication number Publication date
CN111979185B (en) 2022-07-19

Similar Documents

Publication Publication Date Title
GUO et al. Biological features of mesenchymal stem cells from human bone marrow
EP2374871B1 (en) Pluripotent stem cells, method for preparation thereof and uses thereof
Marei et al. Cholinergic and dopaminergic neuronal differentiation of human adipose tissue derived mesenchymal stem cells
CN110938590B (en) A kind of mesenchymal stem cell serum-free medium and use thereof
CN107937338B (en) Mesenchymal stem cell of mesoderm lineage derived from pluripotent stem cells and preparation method thereof
CN111826348B (en) A high-efficiency preparation method and application of human induced pluripotent stem cell-derived mesenchymal stem cells in vitro
CN105039248B (en) Tree shrew mesenchymal stem cell culture systems
CN101575590B (en) Preparation method of human umbilical cord mesenchymal stem cells
CN101173247A (en) A method for cultivating osteoclasts using mesenchymal stem cells combined with cytokines
CN110592007A (en) Mesenchymal stem cell and preparation method and application thereof
CN111979185A (en) Mesenchymal stem cell adipogenic differentiation medium and application thereof
CN103305465B (en) Cultural method of crest-derived stem cell of cranial nerve and identification method
JP2011211956A (en) Undifferentiation-maintaining agent for stem cell and growth-promoting agent
CN114410579B (en) Composition, mesenchymal stem cell serum-free medium containing same and its preparation and application
JP5714267B2 (en) Stem cell undifferentiation maintenance agent and proliferation promoter
JP5710138B2 (en) Stem cell undifferentiation maintenance agent and proliferation promoter
EP3957717B1 (en) Rapid and efficient method for expanding human mesenchymal stem cells in vitro and application thereof
CN110628712B (en) Preparation methods and applications of therapeutic grade mesenchymal stem cells based on induced pluripotent stem cells
CN112662615B (en) Dyeing identification method for induced differentiation of human mesenchymal stem cells into lipid
Wu et al. hMSCs possess the potential to differentiate into DP cells in vivo and in vitro
JP5710145B2 (en) Stem cell undifferentiation maintenance agent and proliferation promoter
CN108148808B (en) Induction medium for the induction of neural precursor cells
CN1920010A (en) Method of separating multipotent adult progenitor cells from umbilical cord blood
CN110468100A (en) The osteogenic induction method of culture medium and mesenchymal stem cell
CN111996162B (en) Chondrogenic differentiation medium and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 215434 No. 66, Anjiang Road, Fuqiao Town, Taicang City, Suzhou City, Jiangsu Province

Applicant after: EXCELL BIOLOGY (TAICANG) CO.,LTD.

Address before: 215434 Room 101 and 102, building 4, No. 52, Yingang Road, taicanggang economic and Technological Development Zone, Suzhou City, Jiangsu Province

Applicant before: EXCELL BIOLOGY (TAICANG) CO.,LTD.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: 215434 No. 66, Anjiang Road, Fuqiao Town, Taicang City, Suzhou City, Jiangsu Province

Patentee after: Suzhou Ecosai Biotechnology Co.,Ltd.

Address before: 215434 No. 66, Anjiang Road, Fuqiao Town, Taicang City, Suzhou City, Jiangsu Province

Patentee before: EXCELL BIOLOGY (TAICANG) CO.,LTD.

CP01 Change in the name or title of a patent holder